These are explanations and solutions for IB past papers, not the official version. For official papers, you can go to IB Follet or access them through your school.
These are explanations and solutions for IB past papers, not the official version. For official papers, you can go to IB Follet or access them through your school.
These are explanations and solutions for IB past papers, not the official version. For official papers, you can go to IB Follet or access them through your school.
These are explanations and solutions for IB past papers, not the official version. For official papers, you can go to IB Follet or access them through your school.
02 Hours 15 Minutes
100 Marks
Calculator NOT allowed
IB BUSINESS MANAGEMENT HL, Paper 1, November, 2010, TZ0, Solved Past Paper
Master the 2010 IB November for Paper 1 Business Management HL with examiner tailored solutions and comments for TZ0
Question 1 [Explained]
N-Pharma is now a successful business, but it initially struggled with poor cash flow, making the early years financially challenging. This question explores the potential problems faced by Yukio Nakamura's business start-up, constructs an Ansoff matrix to show N-Pharma's possible growth strategies, and analyzes the value of social and environmental audits to the company.
Question 1 [a] [Explanation]
This question asks you to outline two problems that Yukio Nakamura's business start-up may have faced during its early years.
Question 1 [b] [Explanation]
This question requires you to construct a fully labelled Ansoff matrix to show N-Pharma's possible growth strategies.
Question 1 [c] [Explanation]
This question asks you to analyze the value of social and environmental audits to N-Pharma.
Question 2 [Explained]
This question involves defining specific business terms and analyzing the effectiveness of leadership and pricing strategies within a pharmaceutical company, N-Pharma. The terms to be defined are 'span of control' and 'empowerment', and the analysis focuses on the leadership style of Susan James and the appropriateness of a cost-based pricing strategy for N-Pharma's drugs.
Question 2 [a] [Explanation]
This part of the question asks you to define two specific business terms: 'span of control' and 'empowerment'.
Question 2 [a] [i] [Explanation]
Define the term 'span of control' as mentioned in line 60.
Question 2 [a] [ii] [Explanation]
Define the term 'empowerment' as mentioned in line 64.
Question 2 [b] [Explanation]
Comment on the effectiveness of Susan James' leadership style in the Canadian subsidiary of N-Pharma.